Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
March 11, 1990
Use of synthetic peptides to establish anti-human acetylcholine receptor CD4+ cell lines from myasthenia gravis patients
M P Protti, A A Manfredi, C Straub, et al.
Cancer Research
|
May 27, 1999
Major histocompatibility complex class I restricted cytotoxic T cells specific for natural melanoma peptides recognize unidentified shared melanoma antigen(s)
M A Imro, S Manici, V Russo, et al.
Annals of the New York Academy of Sciences
|
June 21, 1993
T-helper epitopes on human nicotinic acetylcholine receptor in myasthenia gravis
L Moiola, M P Protti, A A Manfredi, et al.
Journal of Autoimmunity
|
April 1, 1997
TCR V beta usage by acetylcholine receptor-specific CD4+ T cells in myasthenia gravis
R Raju, D Navaneetham, M P Protti, et al.
Cancer Research
|
July 1, 1997
The immunogenicity of experimental tumors is strongly biased by the expression of dominant viral cytotoxic T-lymphocyte epitopes
G Iezzi, L Rivolta, A Ronchetti, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 21, 1998
Processing of engulfed apoptotic bodies yields T cell epitopes
M Bellone, G Iezzi, P Rovere, et al.
International Journal of Cancer
|
May 4, 1999
Blockade of the Fas-triggered intracellular signaling pathway in human melanomas is circumvented by cytotoxic lymphocytes
M Ferrarini, M A Imro, C Sciorati, et al.
The Journal of Clinical Investigation
|
October 11, 1992
Myasthenia gravis. CD4+ T epitopes on the embryonic gamma subunit of human muscle acetylcholine receptor
M P Protti, A A Manfredi, X D Wu, et al.
Cancer Research
|
March 15, 1996
Particulate naturally processed peptides prime a cytotoxic response against human melanoma in vitro
M P Protti, M A Imro, A A Manfredi, et al.
Nature Biotechnology
|
June 29, 1999
Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices
T Sturniolo, E Bono, J Ding, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
Journal of Immunology (Baltimore, Md. : 1950)
|
March 11, 1990
Use of synthetic peptides to establish anti-human acetylcholine receptor CD4+ cell lines from myasthenia gravis patients
M P Protti, A A Manfredi, C Straub, et al.
Cancer Research
|
May 27, 1999
Major histocompatibility complex class I restricted cytotoxic T cells specific for natural melanoma peptides recognize unidentified shared melanoma antigen(s)
M A Imro, S Manici, V Russo, et al.
Annals of the New York Academy of Sciences
|
June 21, 1993
T-helper epitopes on human nicotinic acetylcholine receptor in myasthenia gravis
L Moiola, M P Protti, A A Manfredi, et al.
Journal of Autoimmunity
|
April 1, 1997
TCR V beta usage by acetylcholine receptor-specific CD4+ T cells in myasthenia gravis
R Raju, D Navaneetham, M P Protti, et al.
Cancer Research
|
July 1, 1997
The immunogenicity of experimental tumors is strongly biased by the expression of dominant viral cytotoxic T-lymphocyte epitopes
G Iezzi, L Rivolta, A Ronchetti, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 21, 1998
Processing of engulfed apoptotic bodies yields T cell epitopes
M Bellone, G Iezzi, P Rovere, et al.
International Journal of Cancer
|
May 4, 1999
Blockade of the Fas-triggered intracellular signaling pathway in human melanomas is circumvented by cytotoxic lymphocytes
M Ferrarini, M A Imro, C Sciorati, et al.
The Journal of Clinical Investigation
|
October 11, 1992
Myasthenia gravis. CD4+ T epitopes on the embryonic gamma subunit of human muscle acetylcholine receptor
M P Protti, A A Manfredi, X D Wu, et al.
Cancer Research
|
March 15, 1996
Particulate naturally processed peptides prime a cytotoxic response against human melanoma in vitro
M P Protti, M A Imro, A A Manfredi, et al.
Nature Biotechnology
|
June 29, 1999
Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices
T Sturniolo, E Bono, J Ding, et al.
Page
of 4